The Drug Hypersensitivity Symposium 2026, taking place in Melbourne, Australia, from 23–25 October 2026, brings together international experts to explore the latest evidence and challenges in drug allergy and hypersensitivity.

The programme has a strong focus on cutaneous drug reactions and dermatology, including sessions on severe cutaneous adverse reactions (SCAR), SJS/TEN and drug-induced skin reactions, alongside topics such as antibiotic allergy, perioperative drug allergy, drug challenges and desensitisation.

This meeting will be of particular interest to clinicians and researchers working in drug allergy, dermatology and cutaneous allergy.

For further information and registration, please visit the DHS 2026 conference website.